🇺🇸 fludarabine, cyclophosphamide, doxorubicin, rituximab in United States

fludarabine, cyclophosphamide, doxorubicin, rituximab (fludarabine, cyclophosphamide, doxorubicin, rituximab) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

fludarabine, cyclophosphamide, doxorubicin, rituximab in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is fludarabine, cyclophosphamide, doxorubicin, rituximab approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for fludarabine, cyclophosphamide, doxorubicin, rituximab in United States?

A.O. Ospedale Papa Giovanni XXIII is the originator. The local marketing authorisation holder may differ — check the official source linked above.